Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder

Kevin Berendse, Bart G. P. Koot, Femke C. C. Klouwer, Marc Engelen, Frank Roels, Miangela M. Lacle, Peter G. J. Nikkels, Joanne Verheij, Bwee Tien Poll-The

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Patients with a Zellweger spectrum disorder (ZSD) have a defect in the assembly or maintenance of peroxisomes, leading to a multisystem disease with variable outcome. Liver disease is an important feature in patients with severe and milder phenotypes and a frequent cause of death. However, the course and histology of liver disease in ZSD patients are ill-defined. We reviewed the hepatic symptoms and histological findings of 13 patients with a ZSD in which one or several liver biopsies have been performed (patient age 0.2-39 years). All patients had at least some histological liver abnormalities, ranging from minor fibrosis to cirrhosis. Five patients demonstrated significant disease progression with liver failure and early death. In others, liver-related symptoms were absent, although some still silently developed cirrhosis. Patients with peroxisomal mosaicism had a better prognosis. In addition, we show that patients are at risk to develop a hepatocellular carcinoma (HCC), as one patient developed a HCC at the age of 36 years and one patient a precancerous lesion at the age of 18 years. Thus, regular examination to detect fibrosis or cirrhosis should be included in the standard care of ZSD patients. In case of advanced fibrosis/cirrhosis expert consultation and HCC screening should be initiated. This study further delineates the spectrum and significance of liver involvement in ZSDs.
Original languageEnglish
Pages (from-to)955-965
JournalJournal of Inherited Metabolic Disease
Volume42
Issue number5
DOIs
Publication statusPublished - 1 Sep 2019
Externally publishedYes

Cite this

Berendse, Kevin ; Koot, Bart G. P. ; Klouwer, Femke C. C. ; Engelen, Marc ; Roels, Frank ; Lacle, Miangela M. ; Nikkels, Peter G. J. ; Verheij, Joanne ; Poll-The, Bwee Tien. / Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder. In: Journal of Inherited Metabolic Disease. 2019 ; Vol. 42, No. 5. pp. 955-965.
@article{a2b8a8d6b9d6453cbc29f1dbf7cc41cf,
title = "Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder",
abstract = "Patients with a Zellweger spectrum disorder (ZSD) have a defect in the assembly or maintenance of peroxisomes, leading to a multisystem disease with variable outcome. Liver disease is an important feature in patients with severe and milder phenotypes and a frequent cause of death. However, the course and histology of liver disease in ZSD patients are ill-defined. We reviewed the hepatic symptoms and histological findings of 13 patients with a ZSD in which one or several liver biopsies have been performed (patient age 0.2-39 years). All patients had at least some histological liver abnormalities, ranging from minor fibrosis to cirrhosis. Five patients demonstrated significant disease progression with liver failure and early death. In others, liver-related symptoms were absent, although some still silently developed cirrhosis. Patients with peroxisomal mosaicism had a better prognosis. In addition, we show that patients are at risk to develop a hepatocellular carcinoma (HCC), as one patient developed a HCC at the age of 36 years and one patient a precancerous lesion at the age of 18 years. Thus, regular examination to detect fibrosis or cirrhosis should be included in the standard care of ZSD patients. In case of advanced fibrosis/cirrhosis expert consultation and HCC screening should be initiated. This study further delineates the spectrum and significance of liver involvement in ZSDs.",
author = "Kevin Berendse and Koot, {Bart G. P.} and Klouwer, {Femke C. C.} and Marc Engelen and Frank Roels and Lacle, {Miangela M.} and Nikkels, {Peter G. J.} and Joanne Verheij and Poll-The, {Bwee Tien}",
year = "2019",
month = "9",
day = "1",
doi = "10.1002/jimd.12132",
language = "English",
volume = "42",
pages = "955--965",
journal = "Journal of Inherited Metabolic Disease",
issn = "0141-8955",
publisher = "Springer Netherlands",
number = "5",

}

Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder. / Berendse, Kevin; Koot, Bart G. P.; Klouwer, Femke C. C.; Engelen, Marc; Roels, Frank; Lacle, Miangela M.; Nikkels, Peter G. J.; Verheij, Joanne; Poll-The, Bwee Tien.

In: Journal of Inherited Metabolic Disease, Vol. 42, No. 5, 01.09.2019, p. 955-965.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Hepatic symptoms and histology in 13 patients with a Zellweger spectrum disorder

AU - Berendse, Kevin

AU - Koot, Bart G. P.

AU - Klouwer, Femke C. C.

AU - Engelen, Marc

AU - Roels, Frank

AU - Lacle, Miangela M.

AU - Nikkels, Peter G. J.

AU - Verheij, Joanne

AU - Poll-The, Bwee Tien

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Patients with a Zellweger spectrum disorder (ZSD) have a defect in the assembly or maintenance of peroxisomes, leading to a multisystem disease with variable outcome. Liver disease is an important feature in patients with severe and milder phenotypes and a frequent cause of death. However, the course and histology of liver disease in ZSD patients are ill-defined. We reviewed the hepatic symptoms and histological findings of 13 patients with a ZSD in which one or several liver biopsies have been performed (patient age 0.2-39 years). All patients had at least some histological liver abnormalities, ranging from minor fibrosis to cirrhosis. Five patients demonstrated significant disease progression with liver failure and early death. In others, liver-related symptoms were absent, although some still silently developed cirrhosis. Patients with peroxisomal mosaicism had a better prognosis. In addition, we show that patients are at risk to develop a hepatocellular carcinoma (HCC), as one patient developed a HCC at the age of 36 years and one patient a precancerous lesion at the age of 18 years. Thus, regular examination to detect fibrosis or cirrhosis should be included in the standard care of ZSD patients. In case of advanced fibrosis/cirrhosis expert consultation and HCC screening should be initiated. This study further delineates the spectrum and significance of liver involvement in ZSDs.

AB - Patients with a Zellweger spectrum disorder (ZSD) have a defect in the assembly or maintenance of peroxisomes, leading to a multisystem disease with variable outcome. Liver disease is an important feature in patients with severe and milder phenotypes and a frequent cause of death. However, the course and histology of liver disease in ZSD patients are ill-defined. We reviewed the hepatic symptoms and histological findings of 13 patients with a ZSD in which one or several liver biopsies have been performed (patient age 0.2-39 years). All patients had at least some histological liver abnormalities, ranging from minor fibrosis to cirrhosis. Five patients demonstrated significant disease progression with liver failure and early death. In others, liver-related symptoms were absent, although some still silently developed cirrhosis. Patients with peroxisomal mosaicism had a better prognosis. In addition, we show that patients are at risk to develop a hepatocellular carcinoma (HCC), as one patient developed a HCC at the age of 36 years and one patient a precancerous lesion at the age of 18 years. Thus, regular examination to detect fibrosis or cirrhosis should be included in the standard care of ZSD patients. In case of advanced fibrosis/cirrhosis expert consultation and HCC screening should be initiated. This study further delineates the spectrum and significance of liver involvement in ZSDs.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85070269420&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31150129

U2 - 10.1002/jimd.12132

DO - 10.1002/jimd.12132

M3 - Article

VL - 42

SP - 955

EP - 965

JO - Journal of Inherited Metabolic Disease

JF - Journal of Inherited Metabolic Disease

SN - 0141-8955

IS - 5

ER -